Sonic Healthcare Limited operates as a healthcare company in Australia.
Sonic Healthcare Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$42.12|
|52 Week High||AU$30.21|
|52 Week Low||AU$43.99|
|1 Month Change||-0.66%|
|3 Month Change||11.40%|
|1 Year Change||29.96%|
|3 Year Change||66.55%|
|5 Year Change||90.24%|
|Change since IPO||42,020.00%|
Recent News & Updates
Does Sonic Healthcare (ASX:SHL) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is Sonic Healthcare Limited (ASX:SHL) Worth AU$42.5 Based On Its Intrinsic Value?
How far off is Sonic Healthcare Limited ( ASX:SHL ) from its intrinsic value? Using the most recent financial data...
|SHL||AU Healthcare||AU Market|
Return vs Industry: SHL exceeded the Australian Healthcare industry which returned 23.6% over the past year.
Return vs Market: SHL exceeded the Australian Market which returned 27% over the past year.
Stable Share Price: SHL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: SHL's weekly volatility (2%) has been stable over the past year.
About the Company
Sonic Healthcare Limited operates as a healthcare company in Australia. The company provides laboratory medicine/pathology, diagnostic imaging/radiology, primary care medical services to medical practitioners, hospitals, community health services, and their collective patients. It also offers occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs.
Is Sonic Healthcare undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: SHL (A$42.12) is trading above our estimate of fair value (A$32.85)
Significantly Below Fair Value: SHL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: SHL is good value based on its PE Ratio (15.4x) compared to the Australian Healthcare industry average (26.5x).
PE vs Market: SHL is good value based on its PE Ratio (15.4x) compared to the Australian market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: SHL's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: SHL is overvalued based on its PB Ratio (3.2x) compared to the AU Healthcare industry average (2.4x).
How is Sonic Healthcare forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHL's earnings are forecast to decline over the next 3 years (-18.3% per year).
Earnings vs Market: SHL's earnings are forecast to decline over the next 3 years (-18.3% per year).
High Growth Earnings: SHL's earnings are forecast to decline over the next 3 years.
Revenue vs Market: SHL's revenue is expected to decline over the next 3 years (-2.4% per year).
High Growth Revenue: SHL's revenue is forecast to decline over the next 3 years (-2.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHL's Return on Equity is forecast to be low in 3 years time (9.6%).
How has Sonic Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SHL has high quality earnings.
Growing Profit Margin: SHL's current net profit margins (15%) are higher than last year (7.7%).
Past Earnings Growth Analysis
Earnings Trend: SHL's earnings have grown significantly by 20% per year over the past 5 years.
Accelerating Growth: SHL's earnings growth over the past year (149.2%) exceeds its 5-year average (20% per year).
Earnings vs Industry: SHL earnings growth over the past year (149.2%) exceeded the Healthcare industry 61.3%.
Return on Equity
High ROE: SHL's Return on Equity (20.7%) is considered high.
How is Sonic Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: SHL's short term assets (A$2.3B) exceed its short term liabilities (A$2.2B).
Long Term Liabilities: SHL's short term assets (A$2.3B) do not cover its long term liabilities (A$3.0B).
Debt to Equity History and Analysis
Debt Level: SHL's debt to equity ratio (28%) is considered satisfactory.
Reducing Debt: SHL's debt to equity ratio has reduced from 68.9% to 28% over the past 5 years.
Debt Coverage: SHL's debt is well covered by operating cash flow (112.2%).
Interest Coverage: SHL's interest payments on its debt are well covered by EBIT (20.8x coverage).
What is Sonic Healthcare current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SHL's dividend (2.16%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.3%).
High Dividend: SHL's dividend (2.16%) is low compared to the top 25% of dividend payers in the Australian market (5.41%).
Stability and Growth of Payments
Stable Dividend: SHL's dividends per share have been stable in the past 10 years.
Growing Dividend: SHL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (33%), SHL's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: SHL's dividends in 3 years are forecast to be covered by earnings (68.4% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Colin Goldschmidt (67 yo)
Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt...
CEO Compensation Analysis
Compensation vs Market: Colin's total compensation ($USD3.27M) is about average for companies of similar size in the Australian market ($USD3.56M).
Compensation vs Earnings: Colin's compensation has been consistent with company performance over the past year.
Experienced Management: SHL's management team is seasoned and experienced (20.7 years average tenure).
Experienced Board: SHL's board of directors are seasoned and experienced ( 11.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sonic Healthcare Limited's employee growth, exchange listings and data sources
- Name: Sonic Healthcare Limited
- Ticker: SHL
- Exchange: ASX
- Founded: 1934
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: AU$20.187b
- Shares outstanding: 479.28m
- Website: https://www.sonichealthcare.com
Number of Employees
- Sonic Healthcare Limited
- Grosvenor Place
- Level 22
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 08:03|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.